176 related articles for article (PubMed ID: 18482735)
1. Four human thiopurine s-methyltransferase alleles severely affect protein structure and dynamics.
Rutherford K; Daggett V
J Mol Biol; 2008 Jun; 379(4):803-14. PubMed ID: 18482735
[TBL] [Abstract][Full Text] [Related]
2. Thiopurine S-methyltransferase pharmacogenetics: variant allele functional and comparative genomics.
Salavaggione OE; Wang L; Wiepert M; Yee VC; Weinshilboum RM
Pharmacogenet Genomics; 2005 Nov; 15(11):801-15. PubMed ID: 16220112
[TBL] [Abstract][Full Text] [Related]
3. Human thiopurine S-methyltransferase pharmacogenetics: variant allozyme misfolding and aggresome formation.
Wang L; Nguyen TV; McLaughlin RW; Sikkink LA; Ramirez-Alvarado M; Weinshilboum RM
Proc Natl Acad Sci U S A; 2005 Jun; 102(26):9394-9. PubMed ID: 15967990
[TBL] [Abstract][Full Text] [Related]
4. Enhanced proteasomal degradation of mutant human thiopurine S-methyltransferase (TPMT) in mammalian cells: mechanism for TPMT protein deficiency inherited by TPMT*2, TPMT*3A, TPMT*3B or TPMT*3C.
Tai HL; Fessing MY; Bonten EJ; Yanishevsky Y; d'Azzo A; Krynetski EY; Evans WE
Pharmacogenetics; 1999 Oct; 9(5):641-50. PubMed ID: 10591545
[TBL] [Abstract][Full Text] [Related]
5. Genotyping of thiopurine methyltransferase using pyrosequencing.
Okada Y; Nakamura K; Wada M; Nakamura T; Tsukamoto N; Nojima Y; Horiuchi R; Yamamoto K
Biol Pharm Bull; 2005 Apr; 28(4):677-81. PubMed ID: 15802809
[TBL] [Abstract][Full Text] [Related]
6. Insight into TPMT(∗)23 mutation mis-folding using molecular dynamics simulation and protein structure analysis.
Larif S; Ben Salem C; Soua Z; Hmouda H; Bouraoui K
J Biomol Struct Dyn; 2013 Oct; 31(10):1066-76. PubMed ID: 23025308
[TBL] [Abstract][Full Text] [Related]
7. Characterisation of novel defective thiopurine S-methyltransferase allelic variants.
Garat A; Cauffiez C; Renault N; Lo-Guidice JM; Allorge D; Chevalier D; Houdret N; Chavatte P; Loriot MA; Gala JL; Broly F
Biochem Pharmacol; 2008 Aug; 76(3):404-15. PubMed ID: 18602085
[TBL] [Abstract][Full Text] [Related]
8. Structural characteristics determine the cause of the low enzyme activity of two thiopurine S-methyltransferase allelic variants: a biophysical characterization of TPMT*2 and TPMT*5.
Wennerstrand P; Dametto P; Hennig J; Klingstedt T; Skoglund K; Appell ML; Mårtensson LG
Biochemistry; 2012 Jul; 51(30):5912-20. PubMed ID: 22747506
[TBL] [Abstract][Full Text] [Related]
9. Thiopurine S-Methyltransferase as a Pharmacogenetic Biomarker: Significance of Testing and Review of Major Methods.
Asadov C; Aliyeva G; Mustafayeva K
Cardiovasc Hematol Agents Med Chem; 2017 Nov; 15(1):23-30. PubMed ID: 28552060
[TBL] [Abstract][Full Text] [Related]
10. Structural basis of allele variation of human thiopurine-S-methyltransferase.
Wu H; Horton JR; Battaile K; Allali-Hassani A; Martin F; Zeng H; Loppnau P; Vedadi M; Bochkarev A; Plotnikov AN; Cheng X
Proteins; 2007 Apr; 67(1):198-208. PubMed ID: 17243178
[TBL] [Abstract][Full Text] [Related]
11. Clinical pharmacogenomics of thiopurine S-methyltransferase.
Zhou S
Curr Clin Pharmacol; 2006 Jan; 1(1):119-28. PubMed ID: 18666383
[TBL] [Abstract][Full Text] [Related]
12. Functional characterization of 23 allelic variants of thiopurine S-methyltransferase gene (TPMT*2 - *24).
Ujiie S; Sasaki T; Mizugaki M; Ishikawa M; Hiratsuka M
Pharmacogenet Genomics; 2008 Oct; 18(10):887-93. PubMed ID: 18708949
[TBL] [Abstract][Full Text] [Related]
13. The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations.
Collie-Duguid ES; Pritchard SC; Powrie RH; Sludden J; Collier DA; Li T; McLeod HL
Pharmacogenetics; 1999 Feb; 9(1):37-42. PubMed ID: 10208641
[TBL] [Abstract][Full Text] [Related]
14. Genetic analysis of thiopurine methyltransferase polymorphism in a Japanese population.
Hiratsuka M; Inoue T; Omori F; Agatsuma Y; Mizugaki M
Mutat Res; 2000 Mar; 448(1):91-5. PubMed ID: 10751626
[TBL] [Abstract][Full Text] [Related]
15. Thiopurine methyltransferase gene polymorphisms in Chinese patients with inflammatory bowel disease.
Cao Q; Zhu Q; Shang Y; Gao M; Si J
Digestion; 2009; 79(1):58-63. PubMed ID: 19252404
[TBL] [Abstract][Full Text] [Related]
16. Thiopurine-methyltransferase variants in inflammatory bowel disease: prevalence and toxicity in Brazilian patients.
Carvalho AT; Esberard BC; Fróes RS; Rapozo DC; Grinman AB; Simão TA; Santos JC; Carneiro AJ; Ribeiro-Pinto LF; de Souza HS
World J Gastroenterol; 2014 Mar; 20(12):3327-34. PubMed ID: 24696613
[TBL] [Abstract][Full Text] [Related]
17. Thiopurine S-methytransferase gene polymorphism in rheumatoid arthritis.
Elawi AM; Irshaid YM; Ismail SI; Mustafa KN
Arch Med Res; 2013 Feb; 44(2):105-9. PubMed ID: 23398787
[TBL] [Abstract][Full Text] [Related]
18. One amino acid makes a difference-Characterization of a new TPMT allele and the influence of SAM on TPMT stability.
Iu YPH; Helander S; Kahlin AZ; Cheng CW; Shek CC; Leung MH; Wallner B; Mårtensson LG; Appell ML
Sci Rep; 2017 May; 7():46428. PubMed ID: 28462921
[TBL] [Abstract][Full Text] [Related]
19. Genetic analysis of thiopurine methyltransferase polymorphism in the Jordanian population.
Hakooz N; Arafat T; Payne D; Ollier W; Pushpakom S; Andrews J; Newman W
Eur J Clin Pharmacol; 2010 Oct; 66(10):999-1003. PubMed ID: 20521035
[TBL] [Abstract][Full Text] [Related]
20. Rapid, long-range molecular haplotyping of thiopurine S-methyltransferase (TPMT) *3A, *3B, and *3C.
von Ahsen N; Armstrong VW; Oellerich M
Clin Chem; 2004 Sep; 50(9):1528-34. PubMed ID: 15247157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
